Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation -: Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-κB pathway

被引:343
作者
Marchetti, L
Klein, M
Schlett, K
Pfizenmaier, K
Eisel, ULM
机构
[1] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany
[2] Xantos Biomed AG, D-82152 Martinsried, Germany
[3] Eotvos Lorand Univ, Dept Physiol & Neurobiol, H-1117 Budapest, Hungary
[4] Univ Groningen, Dept Mol Neurobiol, NL-9750 AA Haren, Netherlands
关键词
D O I
10.1074/jbc.M311766200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously shown that two tumor necrosis factor (TNF) receptors (TNFR) exhibit antagonistic functions during neurodegenerative processes in vivo with TNFR1 aggravating and TNFR2 reducing neuronal cell loss, respectively. To elucidate the neuroprotective signaling pathways of TNFR2, we investigated glutamate-induced excitotoxicity in primary cortical neurons. TNF-expressing neurons from TNF-transgenic mice were found to be strongly protected from glutamate-induced apoptosis. Neurons from wild type and TNFR1(-/-) mice prestimulated with TNF or agonistic TNFR2-specific antibodies were also resistant to excitotoxicity, whereas TNFR2(-/-) neurons died upon glutamate and/or TNF exposures. Both protein kinase B/Akt and nuclear factor-kappaB (NF-kappaB) activation were apparent upon TNF treatment. Both TNFR1 and TNFR2 induced the NF-kappaB pathway, yet with distinguishable kinetics and upstream activating components, TNFR1 only induced transient NF-kappaB activation, whereas TNFR2 facilitated long term phosphatidylinositol 3-kinase-dependent NF-kappaB activation strictly. Glutamate-induced triggering of the ionotropic N-methyl-D-aspartate receptor was required for the enhanced and persistent phosphatidylinositol 3-kinase-dependent NF-kappaB activation by TNFR2, indicating a positive cooperation of TNF and neurotransmitter-induced signal pathways. TNFR2-induced persistent NF-kappaB activity was essential for neuronal survival. Thus, the duration of NF-kappaB activation is a critical determinant for sensitivity toward excitotoxic stress and is dependent on a differential upstream signal pathway usage of the two TNFRs.
引用
收藏
页码:32869 / 32881
页数:13
相关论文
共 55 条
[1]  
Akassoglou K, 1997, J IMMUNOL, V158, P438
[2]   Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice - Models for multiple sclerosis with primary oligodendrogliopathy [J].
Akassoglou, K ;
Bauer, J ;
Kassiotis, G ;
Pasparakis, M ;
Lassmann, H ;
Kollias, G ;
Probert, L .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) :801-813
[3]   Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway [J].
Brunet, A ;
Datta, SR ;
Greenberg, ME .
CURRENT OPINION IN NEUROBIOLOGY, 2001, 11 (03) :297-305
[4]   The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[5]   Potential of anticytokine therapies in central nervous system ischaemia [J].
Clark, WM ;
Lutsep, HL .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (02) :227-237
[6]   Essential role of RelA Ser311 phosphorylation by ζPKC in NF-κB transcriptional activation [J].
Duran, A ;
Diaz-Meco, MT ;
Moscat, J .
EMBO JOURNAL, 2003, 22 (15) :3910-3918
[7]   TETANUS TOXIN LIGHT-CHAIN EXPRESSION IN SERTOLI CELLS OF TRANSGENIC MICE CAUSES ALTERATIONS OF THE ACTIN CYTOSKELETON AND DISRUPTS SPERMATOGENESIS [J].
EISEL, U ;
REYNOLDS, K ;
RIDDICK, M ;
ZIMMER, A ;
NIEMANN, H ;
ZIMMER, A .
EMBO JOURNAL, 1993, 12 (09) :3365-3372
[8]  
Eisel ULM, 2002, CURR TOP MICROBIOL, V265, P49
[9]   WEHI-164 SUBCLONE-13 ASSAY FOR TNF - SENSITIVITY, SPECIFICITY, AND RELIABILITY [J].
ESKANDARI, MK ;
NGUYEN, DT ;
KUNKEL, SL ;
REMICK, DG .
IMMUNOLOGICAL INVESTIGATIONS, 1990, 19 (01) :69-79
[10]   Safety and efficacy of disease-modifying anti-rheumatic agents - Focus on the benefits and risks of etanercept [J].
Fleischmann, R ;
Iqbal, I ;
Nandeshwar, P ;
Quiceno, A .
DRUG SAFETY, 2002, 25 (03) :173-197